 Despite a rough day in the market over fears that the Federal Reserve may raise interest rates and thus induce a recession, biopharmaceutical startup Iovance Biotherapeutics NASDAQ: IOVA stock shot up, completely against the grain. Catalyzing robust sentiment toward Iovance was a dramatic example of insider buying. 